FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,551 | -26.7% | 40,826 | +64.6% | 0.00% | -25.0% |
| Q2 2023 | $118,086 | +210767.9% | 24,808 | +152.4% | 0.00% | +100.0% |
| Q1 2023 | $56 | -32.5% | 9,828 | +19.0% | 0.00% | -33.3% |
| Q4 2022 | $83 | -100.0% | 8,260 | -84.7% | 0.00% | -85.0% |
| Q3 2022 | $1,211,000 | +561.7% | 54,039 | +631.6% | 0.02% | +400.0% |
| Q2 2022 | $183,000 | -62.0% | 7,386 | -40.6% | 0.00% | -20.0% |
| Q1 2022 | $482,000 | +108.7% | 12,438 | +215.2% | 0.01% | +25.0% |
| Q4 2021 | $231,000 | +6.5% | 3,946 | +8.0% | 0.00% | -33.3% |
| Q3 2021 | $217,000 | -22.8% | 3,655 | +12.7% | 0.01% | -14.3% |
| Q2 2021 | $281,000 | -85.2% | 3,242 | -85.9% | 0.01% | -78.1% |
| Q1 2021 | $1,895,000 | +188.9% | 22,988 | +218.8% | 0.03% | +60.0% |
| Q4 2020 | $656,000 | +480.5% | 7,211 | +155.3% | 0.02% | +1900.0% |
| Q3 2020 | $113,000 | -72.8% | 2,824 | -76.7% | 0.00% | -94.1% |
| Q2 2020 | $416,000 | +243.8% | 12,119 | +56.1% | 0.02% | +112.5% |
| Q3 2019 | $121,000 | – | 7,766 | +24168.8% | 0.01% | – |
| Q4 2018 | $0 | -100.0% | 32 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $96,000 | +9500.0% | 5,915 | +8231.0% | 0.01% | – |
| Q1 2018 | $1,000 | -97.4% | 71 | -99.3% | 0.00% | -100.0% |
| Q3 2017 | $39,000 | +1850.0% | 9,684 | +1836.8% | 0.00% | – |
| Q3 2016 | $2,000 | -66.7% | 500 | -84.7% | 0.00% | -100.0% |
| Q1 2016 | $6,000 | – | 3,263 | +5525.9% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 58 | -63.8% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 160 | -20.0% | 0.00% | – |
| Q4 2014 | $1,000 | -85.7% | 200 | -86.2% | 0.00% | -100.0% |
| Q3 2014 | $7,000 | +75.0% | 1,449 | +124.3% | 0.00% | 0.0% |
| Q2 2014 | $4,000 | -33.3% | 646 | +7.7% | 0.00% | 0.0% |
| Q1 2014 | $6,000 | -90.9% | 600 | -94.3% | 0.00% | -90.9% |
| Q4 2013 | $66,000 | – | 10,441 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |